Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Familial exudative vitreoretinopathy

Other Names for this Disease
  • Criswick-Schepens syndrome
  • Exudative vitreoretinopathy, familial
  • FEVR
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Newline Maker

How might familial exudative vitreoretinopathy be treated?

Affected individuals with abnormal blood vessel formation in their retina can be treated with laser therapy. Surgery may also be necessary to correct retinal detachment.[1]
Last updated: 3/3/2011

  1. Toomes C & Downey L.. Familial exudative vitreoretinopathy, autosomal dominant. GeneReviews. December 11, 2008; Accessed 3/3/2011.

Management Guidelines

  • GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions. Click on the links below to view articles on the autosomal dominant and the X-linked form of familial exudative vitreoretinopathy.
    Autosomal Dominant FEVR
    X-Linked FEVR

Clinical Trials & Research for this Disease

  • The Centers for Mendelian Genomics program is working to discover the causes of rare genetic disorders. For more information about applying to the research study, please visit their website.
  • lists trials that are studying or have studied Familial exudative vitreoretinopathy. Click on the link to go to to read descriptions of these studies.
  • The U.S. National Institutes of Health, through the National Library of Medicine, developed to provide patients, family members, and members of the public with current information on clinical research studies. There is a study titled Screening Study for the Evaluation and Diagnosis of Potential Research Participants which may be of interest to you. To find this trial, click on the link above.